RNU6-209P

Q-omics provides the consensus-scored RNU6-209P profile across patient tissues and cancer cell-line models. RNU6-209P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in LAML. Additionally, RNU6-209P RNA expression shows 5,889 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight LAML, and LUSC as cancer lineages where RNU6-209P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNU6-209P survival associations across molecular data types. RNU6-209P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-209P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	LAML (18)	view →

This table ranks reproducible RNU6-209P RNA expression–survival associations across cancer types. High RNU6-209P expression shows favorable associations in LAML. The LAML Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .031). Together, the overview and detailed table identify LAML as the clearest survival context for RNU6-209P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	1.000	0.358	.031	18	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RNU6-209P-LAML (DFS)

Explore this curve interactively →